AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2024
May 4, 2024
34491_dirs_2024-05-03_0377bfb0-ad42-4f8d-a93d-c86bfc936630.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2024-02-29
Reporting Person: Kelly John Alexander (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-29 | Common Stock | A | 506 | $18.50 | Acquired | 20978 | Direct |
| 2024-05-01 | Common Stock | M | 1702 | — | Acquired | 22680 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-01 | Restricted Stock Units | $ | M | 1702 | Disposed | Common Stock (1702) | Direct |
Footnotes
F1: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split.
F2: Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024.
F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F4: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.